Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...

Biogen Pharmachem Industries Ltd share price was down by 0.00% from the previous closing price of ₹0.00. Who are peers of Biogen Pharmachem Industries Ltd? The peers of Biogen Pharmachem ...

Biogen exits biosimilar JV with Samsung, raising $2.3bn News The South Korean firm just agreed to buy Biogen out of their biosimilar joint venture – Samsung Bioepis – for $2.3 billion.

CEL-SCI Corporation announced new data has been published from its prior Phase 3 study of Multikine* (Leukocyte Interleukin, Injection) in newly diagnosed, treatment naïve, resectable, locally ...

After hours: March 21 at 7:27:47 PM EDT Loading Chart for BIIB ...

05.03. Mustang Bio, Inc.: Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement 120 GlobeNewswire (Europe) WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc ...

After hours: March 21 at 7:27:47 PM EDT ...

After hours: 20 March at 19:52:57 GMT-4 Loading Chart for BIIB ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Pre-market: 7:05:57 am GMT-4 Loading Chart for BIIB ...